Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] - 1 Jan 2020

Ariston Gabriel Abakundana Nsenga, Jiao Qinlian, Yvette Umwali, Yang Xuemei, Al-Ameri Samed A, Du Lutao, Wang Yun-Shan, Wang Chuanxin

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is among the dangerous human cancers, is the 10th highly prevalent cancer, and the fourth sole cause of cancer-related mortality in the United States of America. Notwithstanding the significant commitment, the forecast for people with this burden continues to have a five-year survival rate of just 4-6%. The most critical altered genes within PDAC consist of K-ras the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mice, Inbred Strains

Share to Mutation

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Mas

Source

Identifiers

PMID: 31780287
DOI: 10.1016/j.pan.2019.11.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance.PMID 31780287Read ↗

Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (<i>LSL‐Kras<sup>G12D/+</sup>;LSL‐Trp53<sup>R172H/+</sup>;Pdx‐1‐Cre</i>), Its Variants, and Their Application in Immuno‐oncology Drug DiscoverySemantic proximity Read ↗

Genetically engineered mouse models of pancreatic adenocarcinomaSemantic proximity Read ↗

Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse ModelsSemantic proximity Read ↗

Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and TherapySemantic proximity Read ↗

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncologySemantic proximity Read ↗

Mouse models of pancreatic cancerSemantic proximity Read ↗

Pancreatic cancer: translating lessons from mouse models and hereditary syndromes.Semantic proximity Read ↗

Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer.Semantic proximity Read ↗

Molecular Pathogenesis of Pancreatic Cancer: Advances and ChallengesSemantic proximity Read ↗

Modeling pancreatic cancer in mice for experimental therapeutics.Semantic proximity Read ↗

A Young Scientist's Guide to PDAC: Past, Present, and FutureSemantic proximity Read ↗

Loss of p53 tumor suppression function drives invasion and genomic instability in models of murine pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.